Christine Rouzioux

Q: What Schools Are Affiliated With Christine Rouzioux

Christine Rouzioux is affiliated with the following schools: Université Paris Cité, Paris Diderot University

Christine Rouzioux's AcademicInfluence.com Rankings

Christine Rouzioux

Philosophy

#5690

World Rank

#8566

Historical Rank

Logic

#2924

World Rank

#4000

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Christine Rouzioux's Degrees

PhD Molecular Biology Université Paris Cité

Why Is Christine Rouzioux Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Christine Rouzioux's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). (1983) (6417)
Isolation of a new human retrovirus from West African patients with AIDS. (1986) (1307)
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. (2015) (1034)
Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes. (1984) (951)
Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study (2013) (895)
Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover (2007) (747)
Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues (1999) (657)
Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. (1996) (641)
Towards an HIV cure: a global scientific strategy (2012) (520)
Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). 1983. (2004) (519)
6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial (1999) (513)
A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. (1989) (415)
HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication. (2005) (371)
Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment. (2009) (362)
Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1. (2001) (357)
Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort (2008) (341)
Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs (2013) (288)
HIV Persistence and the Prospect of Long-Term Drug-Free Remissions for HIV-Infected Individuals (2010) (282)
Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis. (2007) (264)
Estimated timing of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission by use of a Markov model. The HIV Infection in Newborns French Collaborative Study Group. (1995) (261)
Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection. Evidence for a bimodal expression of clinical and biological symptoms. (1990) (248)
Transfer and Evaluation of an Automated, Low-Cost Real-Time Reverse Transcription-PCR Test for Diagnosis and Monitoring of Human Immunodeficiency Virus Type 1 Infection in a West African Resource-Limited Setting (2005) (247)
ISOLATION OF NEW LYMPHOTROPIC RETROVIRUS FROM TWO SIBLINGS WITH HAEMOPHILIA B, ONE WITH AIDS (1984) (245)
Synergistic Activation of HIV-1 Expression by Deacetylase Inhibitors and Prostratin: Implications for Treatment of Latent Infection (2009) (236)
No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception. (2015) (235)
DETECTION OF IgG ANTIBODIES TO LYMPHADENOPATHY-ASSOCIATED VIRUS IN PATIENTS WITH AIDS OR LYMPHADENOPATHY SYNDROME (1984) (228)
HIV-1 infection in an individual homozygous for CCR5▵32 (1997) (217)
Heterogeneity in HIV Suppression by CD8 T Cells from HIV Controllers: Association with Gag-Specific CD8 T Cell Responses1 (2009) (216)
An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression (2015) (216)
Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts. (2013) (209)
CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients. (2006) (205)
DETECTION OF HTV1 DNA IN INFANTS AND CHILDREN BY MEANS OF THE POLYMERASE CHAIN REACTION (1988) (203)
Effects of Recombinant Human Interleukin 7 on T-Cell Recovery and Thymic Output in HIV-Infected Patients Receiving Antiretroviral Therapy: Results of a Phase I/IIa Randomized, Placebo-Controlled, Multicenter Study (2012) (203)
Natural history of serum HIV-1 RNA levels in 330 patients with a known date of infection (2000) (203)
Distinct Genetic Loci Control Plasma HIV-RNA and Cellular HIV-DNA Levels in HIV-1 Infection: The ANRS Genome Wide Association 01 Study (2008) (202)
Morbidity and mortality in European children vertically infected by HIV-1. The French Pediatric HIV Infection Study Group and European Collaborative Study. (1997) (197)
Relation of the course of HIV infection in children to the severity of the disease in their mothers at delivery (1994) (194)
Varicella and zoster in children after kidney transplantation: long-term results of vaccination. (1997) (189)
Long-term immunovirologic control following antiretroviral therapy interruption in patients treated at the time of primary HIV-1 infection (2010) (186)
Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA level (2003) (181)
Retrospective seroepidemiology of AIDS virus infection in Nairobi populations. (1987) (177)
Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load <500 copies/ml at delivery: a case-control study nested in the French perinatal cohort (EPF-ANRS CO1). (2010) (176)
Adipose Tissue Is a Neglected Viral Reservoir and an Inflammatory Site during Chronic HIV and SIV Infection (2015) (174)
Detection of hepatitis C virus in the semen of infected men (2000) (174)
Real-time blood plasma polymerase chain reaction for management of disseminated adenovirus infection. (2004) (167)
Detection and quantification of HIV-1 in semen: identification of a subpopulation of men at high potential risk of viral sexual transmission. (1999) (167)
Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts. (2005) (163)
Development of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: a substudy of pediatric AIDS clinical trials group protocol 316. (2002) (162)
HIV-1 infection in an individual homozygous for CCR5 delta 32. Seroco Study Group. (1997) (162)
Lopinavir/ritonavir monotherapy or plus zidovudine and lamivudine in antiretroviral-naive HIV-infected patients (2008) (160)
Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost? (2012) (159)
Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infection. (1999) (159)
Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy (2006) (158)
Evaluation of clinical case definitions of influenza: detailed investigation of patients during the 1995-1996 epidemic in France. (1999) (155)
HBV and HCV prevalence and viraemia in HIV‐positive and HIV‐negative pregnant women in Abidjan, Côte d'Ivoire: The ANRS 1236 study (2004) (154)
Impact of HIV-1 Genetic Diversity on Plasma HIV-1 RNA Quantification: Usefulness of the Agence Nationale de Recherches sur le SIDA Second-Generation Long Terminal Repeat-Based Real-Time Reverse Transcriptase Polymerase Chain Reaction Test (2007) (152)
Maternal factors associated with perinatal HIV-1 transmission: the French Cohort Study: 7 years of follow-up observation. The French Pediatric HIV Infection Study Group. (1995) (151)
Total HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical Implications (2016) (150)
Semen alterations in HIV-1 infected men. (2002) (147)
The use of viral culture and p24 antigen testing to diagnose human immunodeficiency virus infection in neonates (1992) (143)
French National Sentinel Survey of Antiretroviral Drug Resistance in Patients With HIV-1 Primary Infection and in Antiretroviral-Naive Chronically Infected Patients in 2001-2002 (2005) (142)
Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease (1996) (140)
Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease (1996) (140)
INFLUENZA BURDEN OF ILLNESS: ESTIMATES FROM A NATIONAL PROSPECTIVE SURVEY OF HOUSEHOLD CONTACTS IN FRANCE (2002) (139)
Several groups among human herpesvirus 6 strains can be distinguished by Southern blotting and polymerase chain reaction (1991) (135)
CCR5 chemokine receptor variant in HIV-1 mother-to-child transmission and disease progression in children. French Pediatric HIV Infection Study Group. (1998) (134)
Restriction of HIV-1 replication in macrophages and CD4+ T cells from HIV controllers. (2011) (134)
HIV cure and eradication: how will we get from the laboratory to effective clinical trials? (2011) (130)
Early versus deferred antiretroviral multidrug therapy in infants infected with HIV type 1. (2004) (130)
Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4+ T cells from HIV-1-infected HAART-treated patients (2012) (128)
Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France (2003) (126)
Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial. (2017) (125)
Early protective effect of CCR‐5 Δ32 heterozygosity on HIV‐1 disease progression: relationship with viral load (1997) (123)
Combination of HIV-1-specific CD4 Th1 cell responses and IgG2 antibodies is the best predictor for persistence of long-term nonprogression. (2005) (123)
Prevalence of antibodies to lymphadenopathy-associated retrovirus in African patients with AIDS. (1984) (123)
Lymphadenopathy-associated viral antibody in AIDS. Immune correlations and definition of a carrier state. (1984) (122)
HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report. (2016) (119)
Acceptability and impact of zidovudine for prevention of mother-to-child human immunodeficiency virus-1 transmission in France. (1997) (119)
HIV-1 resistant strains acquired at the time of primary infection massively fuel the cellular reservoir and persist for lengthy periods of time (2006) (119)
Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection: a randomized controlled trial (2003) (117)
Hepatitis C virus in the semen of men coinfected with HIV-1: prevalence and origin (2005) (116)
Immunological and virological efficacy of a therapeutic immunization combined with interleukin-2 in chronically HIV-1 infected patients (2005) (115)
Monitoring Cytomegalovirus Infection in Adult and Pediatric Bone Marrow Transplant Recipients by a Real-Time PCR Assay Performed with Blood Plasma (2003) (114)
Immune responses driven by protective human leukocyte antigen alleles from long-term nonprogressors are associated with low HIV reservoir in central memory CD4 T cells. (2012) (113)
The kidney as a reservoir for HIV-1 after renal transplantation. (2014) (112)
Positive outcomes of HAART at 24 months in HIV-infected patients in Cambodia (2007) (111)
Several groups among human herpesvirus 6 strains can be distinguished by Southern blotting and polymerase chain reaction (1992) (111)
Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIV‐infected patients (1994) (111)
A prospective study of infants born to women seropositive for human immunodeficiency virus type 1 (1990) (111)
Impact of the Timing of Initiation of Antiretroviral Therapy During Primary HIV-1 Infection on the Decay of Cell-Associated HIV-DNA. (2015) (110)
Replication-competent HIV strains infect HIV controllers despite undetectable viremia (ANRS EP36 study) (2007) (106)
Hiv-1 Control after Transient Antiretroviral Treatment Initiated in Primary Infection: Role of Patient Characteristics and Effect of Therapy (2012) (106)
Penetration of enfuvirtide, tenofovir, efavirenz, and protease inhibitors in the genital tract of HIV-1-infected men (2004) (105)
Elite controllers as a model of functional cure (2011) (105)
LTR real-time PCR for HIV-1 DNA quantitation in blood cells for early diagnosis in infants born to seropositive mothers treated in HAART area (ANRS CO 01). (2009) (104)
ABSENCE OF ANTIBODIES TO AIDS VIRUS IN HAEMOPHILIACS TREATED WITH HEAT-TREATED FACTOR VIII CONCENTRATE (1985) (103)
Long-term survival and immuno-virological response of African HIV-1-infected children to highly active antiretroviral therapy regimens (2006) (100)
Evidence of genotypic resistance diversity of archived and circulating viral strains in blood and semen of pre-treated HIV-infected men (2004) (98)
The Th17/Treg Ratio, IL-1RA and sCD14 Levels in Primary HIV Infection Predict the T-cell Activation Set Point in the Absence of Systemic Microbial Translocation (2013) (98)
Long-term outcomes in adolescents perinatally infected with HIV-1 and followed up since birth in the French perinatal cohort (EPF/ANRS CO10). (2010) (97)
Tritherapy for human immunodeficiency virus infection does not modify replication of hepatitis C virus in coinfected subjects. (1998) (95)
HIV type 1-infected dendritic cells induce apoptotic death in infected and uninfected primary CD4 T lymphocytes. (2004) (93)
Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission. (2015) (93)
Elevated IP10 levels are associated with immune activation and low CD4+ T-cell counts in HIV controller patients (2014) (92)
Multiple-cohort genetic association study reveals CXCR6 as a new chemokine receptor involved in long-term nonprogression to AIDS. (2010) (91)
The lymphocyte HIV reservoir in patients on long-term HAART is a memory of virus evolution (2004) (89)
Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease. The French Pediatric HIV Infection Study Group. (1996) (89)
ISOLATION OF HUMAN T-LYMPHOTROPIC RETROVIRUS (LAV) FROM ZAIRIAN MARRIED COUPLE, ONE WITH AIDS, ONE WITH PRODROMES (1984) (89)
Decreased risk of congenital cytomegalovirus infection in children born to HIV-1-infected mothers in the era of highly active antiretroviral therapy. (2009) (89)
Stable frequency of HIV-1 transmitted drug resistance in patients at the time of primary infection over 1996–2006 in France (2009) (88)
Pediatric viral human immunodeficiency virus type 1 RNA levels, timing of infection, and disease progression in African HIV-1-infected children. (2003) (88)
HIV type 1-specific IgG2 antibodies: markers of helper T cell type 1 response and prognostic marker of long-term nonprogression. (2001) (86)
Low risk of nevirapine resistance mutations in the prevention of mother-to-child transmission of HIV-1: Agence Nationale de Recherches sur le SIDA Ditrame Plus, Abidjan, Cote d'Ivoire. (2006) (86)
Non-Disclosure of a Pregnant Woman’s HIV Status to Her Partner is Associated with Non-Optimal Prevention of Mother-to-Child Transmission (2013) (85)
Impact of antiretroviral therapy and changes in virus load on human immunodeficiency virus (HIV)-specific T cell responses in primary HIV infection. (2003) (83)
Sustained control of viremia following therapeutic immunization in chronically HIV-1-infected individuals (2006) (83)
Association Between Medication Possession Ratio, Virologic Failure and Drug Resistance in HIV-1–Infected Adults on Antiretroviral Therapy in Côte d'Ivoire (2011) (83)
Field Evaluation of a Rapid Human Immunodeficiency Virus (HIV) Serial Serologic Testing Algorithm for Diagnosis and Differentiation of HIV Type 1 (HIV-1), HIV-2, and Dual HIV-1-HIV-2 Infections in West African Pregnant Women (2004) (83)
Performance of HIV-1 DNA or HIV-1 RNA tests for early diagnosis of perinatal HIV-1 infection during anti-retroviral prophylaxis. (2012) (82)
Universal antiretroviral therapy for pregnant and breast-feeding HIV-1-infected women: towards the elimination of mother-to-child transmission of HIV-1 in resource-limited settings. (2009) (82)
Antibodies to conserved epitopes of the HIV-1 envelope in sera from long-term non-progressors: prevalence and association with neutralizing activity (2006) (81)
No relation between in-utero exposure to HAART and intrauterine growth retardation (2009) (78)
HIV-1 RNA detection in plasma for the diagnosis of infection in neonates. The French Pediatric HIV Infection Study Group. (1997) (78)
Spontaneous control of viral replication during primary HIV infection: when is "HIV controller" status established? (2009) (77)
Does transient HAART during primary HIV-1 infection lower the virological set-point? (2004) (73)
High frequency of X4/DM-tropic viruses in PBMC samples from patients with primary HIV-1 subtype-B infection in 1996-2007: the French ANRS CO06 PRIMO Cohort Study. (2009) (72)
Protective effect of interleukin-4 -589T polymorphism on human immunodeficiency virus type 1 disease progression: relationship with virus load. (2002) (71)
Acute HIV infection after acupuncture treatments. (1989) (71)
HIV-DNA in rectal cells is well correlated with HIV-DNA in blood in different groups of patients, including long-term non-progressors (2008) (71)
Decrease in HIV-1 seminal shedding in men receiving highly active antiretroviral therapy: an 18 month longitudinal study (ANRS EP012). (2002) (70)
Sequential treatment with 5‐aza‐2′‐deoxycytidine and deacetylase inhibitors reactivates HIV‐1 (2015) (70)
Early diagnosis of paediatric HIV-1 infection among African breast-fed children using a quantitative plasma HIV RNA assay (2001) (69)
Early control of HIV replication in primary HIV-1 infection treated with antiretroviral drugs and pegylated IFN alpha: results from the Primoferon A (ANRS 086) Study. (2001) (69)
Timing of mother‐to‐child HIV‐1 transmission depends on maternal status (1993) (69)
Amniocentesis and mother-to-child human immunodeficiency virus transmission in the Agence Nationale de Recherches sur le SIDA et les Hépatites Virales French Perinatal Cohort. (2009) (69)
Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: relationship with viral load. The SEROCO Study Group. (1997) (69)
Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006. (2008) (68)
Screening for lymphadenopathy/AIDS virus in bone marrow-transplant recipients. (1986) (68)
Lymphadenopathy-associated virus isolated from bronchoalveolar lavage fluid in AIDS-related complex with lymphoid interstitial pneumonitis. (1985) (68)
A Single HIV-1 Cluster and a Skewed Immune Homeostasis Drive the Early Spread of HIV among Resting CD4+ Cell Subsets within One Month Post-Infection (2013) (68)
Status of long‐term asymptomatic HIV‐1 infection correlates with viral load but not with virus replication properties and cell tropism (1999) (68)
The HIV RNA setpoint theory revisited (2007) (68)
Increasing HIV-1 non-B subtype primary infections in patients in France and effect of HIV subtypes on virological and immunological responses to combined antiretroviral therapy. (2013) (67)
Prevalence and clinical impact of norovirus fecal shedding in children with inherited immune deficiencies. (2012) (67)
Detection of HIV-1 in seminal plasma and seminal cells of HIV-1 seropositive men. (1998) (67)
Frequent detection of HIV-1 in the gastric aspirates of neonates born to HIV-infected mothers. (1999) (66)
Genotypic Human Immunodeficiency Virus Type 1 Drug Resistance in Highly Active Antiretroviral Therapy-Treated Children in Abidjan, Côte d'Ivoire (2005) (65)
Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era? (2013) (65)
Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial. (2015) (63)
Increase in hepatitis C virus incidence in HIV-1-infected patients followed up since primary infection (2006) (63)
Passive immunotherapy in AIDS: a randomized trial of serial human immunodeficiency virus-positive transfusions of plasma rich in p24 antibodies versus transfusions of seronegative plasma. (1992) (62)
A low HIV-DNA level in peripheral blood mononuclear cells at antiretroviral treatment interruption predicts a higher probability of maintaining viral control (2015) (62)
Frequent occurrence of chronic hepatitis B virus infection among West African HIV type-1-infected children. (2008) (61)
HIV-1 DNA for the measurement of the HIV reservoir is predictive of disease progression in seroconverters whatever the mode of result expression is. (2008) (60)
Protease Inhibitor Resistance Analysis in the MONARK Trial Comparing First-Line Lopinavir-Ritonavir Monotherapy to Lopinavir-Ritonavir plus Zidovudine and Lamivudine Triple Therapy (2009) (60)
Description of an adenovirus A31 outbreak in a paediatric haematology unit (2006) (59)
Assisted reproduction in HIV-1-serodifferent couples: the need for viral validation of processed semen (2002) (59)
Isolation of a new retrovirus in a patient at risk for acquired immunodeficiency syndrome. (1983) (58)
Timing of mother-to-child HIV-1 transmission and diagnosis of infection based on polymerase chain reaction in the neonatal period by a non-parametric method. (1997) (58)
Early multitherapy including a protease inhibitor for human immunodeficiency virus type 1-infected infants (2002) (58)
Population Analysis of Weight-, Age-, and Sex-Related Differences in the Pharmacokinetics of Lopinavir in Children from Birth to 18 Years (2006) (58)
Cerebral venous thrombosis and dual primary infection with human immunodeficiency virus and cytomegalovirus. (1989) (57)
Interruption of antiretroviral therapy initiated during primary HIV-1 infection: impact of a therapeutic vaccination strategy combined with interleukin (IL)-2 compared with IL-2 alone in the ANRS 095 Randomized Study. (2007) (57)
Early HIV-specific cytotoxic T lymphocytes and disease progression in children born to HIV-infected mothers. (1998) (56)
Relationship between Regulatory T Cells and Immune Activation in Human Immunodeficiency Virus-Infected Patients Interrupting Antiretroviral Therapy (2010) (55)
Human Cytomegalovirus UL144 Gene Polymorphisms in Congenital Infections (2005) (54)
Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trial. (2013) (54)
Molecular identification of viruses in sudden infant death associated with myocarditis and pericarditis. (1995) (53)
CD4 Dynamics over a 15 Year-Period among HIV Controllers Enrolled in the ANRS French Observatory (2011) (53)
Inverse correlation between memory Gag-specific cytotoxic T lymphocytes and viral replication in human immunodeficiency virus-infected children. (2002) (52)
Dendritic cells generated in the presence of granulocyte-macrophage colony-stimulating factor and IFN-α are potent inducers of HIV-specific CD8 T cells (2003) (51)
CCR5 delta32 deletion and response to highly active antiretroviral therapy in HIV-1-infected patients. (2000) (51)
Frequencies of Ex Vivo-Activated Human Immunodeficiency Virus Type 1-Specific Gamma-Interferon-Producing CD8+ T Cells in Infected Children Correlate Positively with Plasma Viral Load (2002) (51)
Impact of heterozygosity for the chemokine receptor CCR5 32-bp-deleted allele on plasma virus load and CD4 T lymphocytes in perinatally human immunodeficiency virus-infected children at 8 years of age. (1998) (51)
Elevated Basal Pre-infection CXCL10 in Plasma and in the Small Intestine after Infection Are Associated with More Rapid HIV/SIV Disease Onset (2016) (50)
Impact of Nevirapine (NVP) Plasma Concentration on Selection of Resistant Virus in Mothers Who Received Single-Dose NVP To Prevent Perinatal Human Immunodeficiency Virus Type 1 Transmission and Persistence of Resistant Virus in Their Infected Children (2006) (50)
Genotypic resistance profiles of HIV-2-treated patients in West Africa (2014) (50)
Cross-clade-specific cytotoxic T lymphocytes in HIV-1-infected children. (1998) (50)
A Prospective Study of Infants Born to Women Seropositive for Human Immunodeficiency Virus Type I (1990) (50)
How to best measure HIV reservoirs? (2013) (49)
Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapy (2010) (49)
Mother-to-child transmission of HIV-2 infection from 1986 to 2007 in the ANRS French Perinatal Cohort EPF-CO1. (2010) (49)
HIV RNA and HIV DNA in peripheral blood mononuclear cells are consistent markers for estimating viral load in patients undergoing long-term potent treatment. (2000) (49)
Despite being highly diverse, immunovirological status strongly correlates with clinical symptoms during primary HIV-1 infection: a cross-sectional study based on 674 patients enrolled in the ANRS CO 06 PRIMO cohort. (2010) (48)
Evaluation of an Upgraded Version of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 Test for HIV-1 Load Quantification (2010) (48)
18-Month Effectiveness of Short-Course Antiretroviral Regimens Combined with Alternatives to Breastfeeding to Prevent HIV Mother-to-Child Transmission (2008) (48)
French 2013 guidelines for antiretroviral therapy of HIV-1 infection in adults (2014) (47)
High rebound of plasma and cellular HIV load after discontinuation of triple combination therapy. (1998) (46)
HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007-12: impact on susceptibility to first-line strategies. (2015) (46)
The measurement of HIV-1 viral load in resource-limited settings: how and where? (2007) (46)
Recent HIV-1 Infection Contributes to the Viral Diffusion over the French Territory with a Recent Increasing Frequency (2012) (45)
A high HIV DNA level in PBMCs at antiretroviral treatment interruption predicts a shorter time to treatment resumption, independently of the CD4 nadir (2010) (45)
Structured Treatment Interruptions in Primary HIV-1 Infection: The ANRS 100 PRIMSTOP Trial (2005) (45)
Lymphadenopathy associated virus and its etiological role in AIDS. (1984) (44)
Total HIV DNA: a global marker of HIV persistence (2018) (44)
Spatiotemporal dynamics of HIV-1 transmission in France (1999–2014) and impact of targeted prevention strategies (2017) (44)
Long-Term Spontaneous Control of HIV-1 Is Related to Low Frequency of Infected Cells and Inefficient Viral Reactivation (2015) (43)
Prevention of mother-to-child HIV transmission: similar access for sub-Sahara African immigrants and for French women? (2008) (43)
HIV-1 DNA levels in peripheral blood mononuclear cells and cannabis use are associated with intermittent HIV shedding in semen of men who have sex with men on successful antiretroviral regimens. (2014) (43)
Genotypic drug resistance during HIV-1 primary infection in France (1996-1999): frequency and response to treatment. (2002) (43)
Frequency and phenotyping of human immunodeficiency virus (HIV)-specific CD8+ T cells in HIV-infected children, using major histocompatibility complex class I peptide tetramers. (2001) (43)
Response to HAART in French patients with resistant HIV-1 treated at primary infection: ANRS Resistance Network (2007) (42)
Long-term nonprogression of HIV infection in children: evaluation of the ANRS prospective French Pediatric Cohort. (2007) (42)
Both HLA-B*57 and Plasma HIV RNA Levels Contribute to the HIV-Specific CD8+ T Cell Response in HIV Controllers (2013) (42)
Effect of perinatal zidovudine prophylaxis on the evolution of cell-free HIV-1 RNA in breast milk and on postnatal transmission. (2004) (41)
Early Control of HIV-1 Infection in Long-Term Nonprogressors Followed Since Diagnosis in the ANRS SEROCO/HEMOCO Cohort (2009) (40)
Two-months-off, four-months-on antiretroviral regimen increases the risk of resistance, compared with continuous therapy: a randomized trial involving West African adults. (2009) (40)
HHV‐6 and EBV DNA quantitation in lymph nodes of 86 patients with Hodgkin's lymphoma (2007) (39)
Stimulation of the primary anti‐HIV antibody response by IFN‐α in patients with acute HIV‐1 infection (2008) (39)
Absence of HIV-1 shedding in male genital tract after 1 year of first-line lopinavir/ritonavir alone or in combination with zidovudine/lamivudine. (2008) (38)
Polymorphism in Gag Gene Cleavage Sites of HIV-1 Non-B Subtype and Virological Outcome of a First-Line Lopinavir/Ritonavir Single Drug Regimen (2011) (38)
Comparative Assessment of Quantitative HIV Viraemia Assays (1992) (38)
Predictive Factors of Virologic Success in HIV-1–Infected Children Treated With Lopinavir/Ritonavir (2004) (37)
Blimp-1 overexpression is associated with low HIV-1 reservoir and transcription levels in central memory CD4+ T cells from elite controllers (2014) (37)
Direct HIV testing in blood donations: variation of the yield with detection threshold and pool size (1999) (37)
Field Evaluation of an Improved Assay Using a Heat‐Dissociated p24 Antigen for Adults Mainly Infected With HIV‐1 CRF02_AG Strains in Côte d’Ivoire, West Africa (2003) (36)
Lung in acquired immune deficiency syndrome: infectious and immunological status assessed by bronchoalveolar lavage. (1985) (36)
NKG2C+ memory-like NK cells contribute to the control of HIV viremia during primary infection: Optiprim-ANRS 147 (2017) (36)
Failure of bone marrow transplantation to eradicate HIV reservoir despite efficient HAART. (2007) (36)
Undetectable viremia without antiretroviral therapy in patients with HIV seroconversion: an uncommon phenomenon? (2005) (36)
No evidence of a change in HIV-1 virulence since 1996 in France (2009) (35)
Continuous versus intermittent treatment strategies during primary HIV-1 infection: the randomized ANRS INTERPRIM Trial (2012) (35)
Detection of HIV1 DNA in infants and children by means of the polymerase chain reaction. (1988) (35)
Tolerance and viral resistance after single-dose nevirapine with tenofovir and emtricitabine to prevent vertical transmission of HIV-1. (2009) (35)
A virologic survey of patients admitted to a critical care unit for acute cardiorespiratory failure (2005) (34)
Characteristics of HIV-infected children recently diagnosed in Paris, France (2006) (34)
Long-term follow-up of 120 patients with AIDS-related Kaposi's sarcoma treated with interferon alpha-2a. (1990) (34)
A Subset of Extreme Human Immunodeficiency Virus (HIV) Controllers Is Characterized by a Small HIV Blood Reservoir and a Weak T-Cell Activation Level (2017) (34)
Integrase strand transfer inhibitors and neuropsychiatric adverse events in a large prospective cohort (2018) (34)
Factors influencing peripheral blood mononuclear cell-associated HIV-1 DNA level after long-term suppressive antiretroviral therapy in 236 patients (2009) (33)
Alpha interferon administration during structured interruptions of combination antiretroviral therapy in patients with chronic HIV-1 infection: INTERVAC ANRS 105 trial (2011) (33)
Immunological and virological effects of long term IL-2 therapy in HIV-1-infected patients. (2001) (32)
Sexually transmitted hepatitis C virus superinfection in HIV/hepatitis C virus co-infected men who have sex with men (2008) (32)
Transient antibody to lymphadenopathy-associated virus/human T-lymphotropic virus type III and T-lymphocyte abnormalities in the wife of a man who developed the acquired immunodeficiency syndrome. (1985) (31)
Delayed virus-specific CD8+ cytotoxic T lymphocyte activity in an HIV-infected individual with high CD4+ cell counts: correlations with various parameters of disease progression. (1996) (31)
New and old complex recombinant HIV-1 strains among patients with primary infection in 1996–2006 in France: The French ANRS CO06 primo cohort study (2008) (31)
Reactivation capacity by latency-reversing agents ex vivo correlates with the size of the HIV-1 reservoir (2017) (31)
Rapid CD4+ Cell Decrease After Transient cART Initiated During Primary HIV Infection (ANRS PRIMO and SEROCO Cohorts) (2008) (31)
Lymphadenopathy syndrome in two thalassemic patients after LAV contamination by blood transfusion. (1985) (30)
Detailed analysis of the genetic evolution of influenza virus during the course of an epidemic (2005) (30)
TRANSPLACENTAL TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS (1986) (30)
Tuning of AKT-pathway by Nef and its blockade by protease inhibitors results in limited recovery in latently HIV infected T-cell line (2016) (30)
Timing of human immunodeficiency virus type 1 (HIV-1) transmission from mother to child: bayesian estimation using a mixture. (1999) (30)
Influenza and influenza-like illness in general practice: drawing lessons for surveillance from a pilot study in Paris, France. (1997) (30)
HIV-Specific B Cell Frequency Correlates with Neutralization Breadth in Patients Naturally Controlling HIV-Infection (2017) (30)
Prevalence and risk factors associated with antiretroviral resistance in HIV‐1‐infected children (2007) (30)
HIV-1 viral load testing cost in developing countries: what’s new? (2007) (29)
Blood Epstein–Barr virus DNA load and risk of progression to AIDS‐related systemic B lymphoma (2012) (29)
Multicenter Quality Control for the Detection of Hepatitis C Virus RNA in Seminal Plasma Specimens (2003) (29)
Selection of a rare resistance profile in an HIV-1-infected patient exhibiting a failure to an antiretroviral regimen including tenofovir DF. (2005) (29)
Isolation of lymphadenopathy-associated virus (LAV) and detection of LAV antibodies from US patients with AIDS. (1985) (29)
Quantification of total HIV1-DNA in peripheral blood mononuclear cells. (2014) (28)
Cytomegalovirus colitis in patients with acquired immunodeficiency syndrome (1988) (28)
Relationships between HIV disease history and blood HIV-1 DNA load in perinatally infected adolescents and young adults: the ANRS-EP38-IMMIP study. (2012) (27)
Nevirapine or efavirenz for tuberculosis and HIV coinfected patients: exposure and virological failure relationship (2014) (27)
HIV proteins absent from placentas of 75 HIV-1-positive women studied by immunohistochemistry. (1991) (27)
Immunoglobulin G antibodies to lymphadenopathy-associated virus in differently treated French and Belgian hemophiliacs. (1985) (27)
Status of long-term asymptomatic HIV-1 infection correlates with viral load but not with virus replication properties and cell tropism. French ALT Study Group. (1999) (26)
Apparent enhancement of perinatal transmission of human immunodeficiency virus type 1 by high maternal anti-gp160 antibody titer. (1998) (26)
HIV-1 DNA in Peripheral Blood Mononuclear Cells Is Strongly Associated With HIV-1 Disease Progression in Recently Infected West African Adults (2008) (26)
POSSIBLE TRANSMISSION OF A HUMAN LYMPHOTROPIC RETROVIRUS (LAV) FROM MOTHER TO INFANT WITH AIDS (1984) (25)
Field investigation of influenza vaccine effectiveness on morbidity. (1998) (25)
Impact of early cART on HIV blood and semen compartments at the time of primary infection (2017) (25)
Long-term Therapeutic Impact of the Timing of Antiretroviral Therapy in Patients Diagnosed With Primary Human Immunodeficiency Virus Type 1 Infection (2018) (25)
Polyfunctional HIV-specific T cells in Post-Treatment Controllers. (2016) (25)
Greater diversity of HIV DNA variants in the rectum compared to variants in the blood in patients without HAART (2011) (25)
CCR5 Δ32 Deletion and Reduced Risk of Toxoplasmosis in Persons Infected with Human Immunodeficiency Virus Type 1 (1999) (25)
Cot death and myocarditis (1992) (25)
Late postnatal HIV infection in children born to HIV-1-infected mothers in a high-income country (2010) (24)
Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3 (2018) (24)
Plasma HIV-2 RNA According to CD4 Count Strata among HIV-2-Infected Adults in the IeDEA West Africa Collaboration (2015) (24)
Gene transfer of anti-gp41 antibody and CD4 immunoadhesin strongly reduces the HIV-1 load in humanized severe combined immunodeficient mice (2000) (24)
Increasing Rate of TAMs and Etravirine Resistance in HIV-1–Infected Adults Between 12 and 24 Months of Treatment: The VOLTART Cohort Study in Côte d’Ivoire, West Africa (2013) (24)
Low Frequency of CXCR4-Using Viruses in Patients at the Time of Primary Non-Subtype-B HIV-1 Infection (2010) (24)
Recent changes in the management of primary HIV‐1 infection: results from the French PRIMO cohort (2004) (24)
Mortality Among HIV-1-Infected Women According to Children's Feeding Modality: An Individual Patient Data Meta-Analysis (2005) (24)
New Sensitive One-Step Real-Time Duplex PCR Method for Group A and B HIV-2 RNA Load (2014) (23)
Prevalence, Risk Factors, and Impact on Outcome of Cytomegalovirus Replication in Serum of Cambodian HIV-Infected Patients (2004-2007) (2009) (23)
Perinatal acquisition of drug-resistant HIV-1 infection: mechanisms and long-term outcome (2009) (23)
Change to a Once-Daily Combination Including Boosted Atazanavir in HIV-1-Infected Children (2006) (23)
A Mature NK Profile at the Time of HIV Primary Infection Is Associated with an Early Response to cART (2017) (23)
Cidofovir may be deleterious in BK virus-associated nephropathy. (2010) (23)
A highly virulent variant of HIV-1 circulating in the Netherlands (2022) (23)
Risk of Extended Viral Resistance in Human Immunodeficiency Virus-1-Infected Mozambican Children After First-Line Treatment Failure (2009) (22)
No evidence for proliferation in the blood CD4+ T‐cell pool during HIV‐1 infection and triple combination therapy (1998) (22)
[LAV type II: a second retrovirus associated with AIDS in West Africa]. (1986) (22)
Effect of intermittent interleukin-2 therapy on CD4+ T-cell counts following antiretroviral cessation in patients with HIV (2012) (22)
Examination of real-time PCR for HIV-1 RNA and DNA quantitation in patients infected with HIV-1 BF intersubtype recombinant variants. (2007) (22)
Influence of lifelong cumulative HIV viremia on long-term recovery of CD4+ cell count and CD4+/CD8+ ratio among patients on combination antiretroviral therapy (2015) (22)
Impact of 48 week lopinavir/ritonavir monotherapy on blood cell-associated HIV-1-DNA in the MONARK trial. (2010) (22)
Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial. (2013) (22)
Causal Pathways of the Effects of Age and the CCR5-Δ32, CCR2-64I, and SDF-1 3′A Alleles on AIDS Development (2005) (22)
Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion. (2013) (21)
Distinct differentiation profiles of HIV-Gag and Nef-specific central memory CD8+ T cells associated with HLA-B57/5801 and virus control (2010) (21)
Characteristics of the env Genes of HIV Type 1 Quasispecies in Long-Term Nonprogressors With Broadly Neutralizing Antibodies (2008) (21)
Impact of highly active antiretroviral therapy on the maturation of anti‐HIV‐1 antibodies during primary HIV‐1 infection (2006) (21)
Sexually-Transmitted/Founder HIV-1 Cannot Be Directly Predicted from Plasma or PBMC-Derived Viral Quasispecies in the Transmitting Partner (2013) (21)
Impact of HIV type 1 DNA levels on spontaneous disease progression: a meta-analysis. (2012) (21)
Lopinavir/Ritonavir-based Antiretroviral Therapy in Human Immunodeficiency Virus Type 1-infected Naive Children: Rare Protease Inhibitor Resistance Mutations But High Lamivudine/Emtricitabine Resistance at the Time of Virologic Failure (2011) (21)
Dynamics in HIV‐DNA levels over time in HIV controllers (2019) (21)
Perinatal HIV transmission facts and controversies. (1992) (20)
Zidovudine Genotypic Resistance in HIV‐1‐Infected Newborns in the French Perinatal Cohort (2001) (20)
Naive T lymphocytes and recent thymic emigrants are associated with HIV-1 disease history in french adolescents and young adults infected in the perinatal period: the ANRS-EP38-IMMIP study. (2014) (20)
Short communication: evidence of HIV type 1 complex and second generation recombinant strains among patients infected in 1997-2007 in France: ANRS CO06 PRIMO Cohort. (2010) (20)
Circulation of multiple patterns of unique recombinant forms B/CRF02_AG in France: precursor signs of the emergence of an upcoming CRF B/02 (2011) (20)
Posttreatment controllers: what do they tell us? (2015) (20)
Separation between HIV-positive women and their children: the French prospective study, 1986 through 1993. (1996) (20)
Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant (1997) (20)
CD8 T-Cells from Most HIV-Infected Patients Lack Ex Vivo HIV-Suppressive Capacity during Acute and Early Infection (2013) (20)
Patient-Specific Cytotoxic T-Lymphocyte Cross-Recognition of Naturally Occurring Variants of a Human Immunodeficiency Virus Type 1 (HIV-1) p24gagEpitope by HIV-1-Infected Children (2001) (20)
Immunovirological response to combined antiretroviral therapy and drug resistance patterns in children: 1- and 2-year outcomes in rural Uganda (2011) (19)
Correction: How much would the safety of blood transfusion be improved by including p24 antigen in the battery of tests? (1995) (19)
No detection of HIV 1-RNA in semen of men on efficient HAART in the past 4 years of a 2002–2009 survey (2010) (19)
T-cell activation positively correlates with cell-associated HIV-DNA level in viremic patients with primary or chronic HIV-1 infection (2014) (19)
Not All Tetramer Binding CD8+ T Cells Can Produce Cytokines and Chemokines Involved in the Effector Functions of Virus-Specific CD8+ T Lymphocytes in HIV-1 Infected Children (2005) (18)
Improved virological response to highly active antiretroviral therapy in HIV‐1‐infected patients carrying the CCR5 Δ32 deletion (2007) (18)
Hepatic Toxicity Associated with 2′-3'Dideoxyinosine in Children with AIDS (1995) (18)
Prognostic factors for virological response in antiretroviral therapy-naive patients in the MONARK Trial randomized to ritonavir-boosted lopinavir alone (2009) (18)
First case of mother-to-infant HIV type 1 group O transmission and evolution of C2V3 sequences in the infected child. French HIV Pediatric Cohort Study Group. (1998) (18)
Comparison of Early CD4 T-Cell Count in HIV-1 Seroconverters in Côte d'Ivoire and France: The ANRS PRIMO-CI and SEROCO Cohorts (2010) (18)
Infection par le VIH et grossesse : nouvelles recommandations 2013 du groupe d’experts français (2014) (17)
Primary HIV-1 infection in African children infected through breastfeeding (2002) (17)
Human cytomegalovirus (HCMV) short tandem repeats analysis in congenital infection. (2005) (17)
Previous Antiretroviral Therapy for Prevention of Mother-to-Child Transmission of HIV Does not Hamper the Initial Response to PI-Based Multitherapy During Subsequent Pregnancy (2011) (17)
The frequency of HIV-specific interferon- gamma -producing CD8 T cells is associated with both age and level of antigenic stimulation in HIV-1-infected children. (2005) (17)
Drug resistance and tropism as markers of the dynamics of HIV-1 DNA quasispecies in blood cells of heavily pretreated patients who achieved sustained virological suppression. (2016) (17)
Higher HIV-1 DNA associated with lower gains in CD4 cell count among patients with advanced therapeutic failure receiving optimized treatment (ANRS 123--ETOILE). (2010) (17)
Tests de dépistage combiné des anticorps anti-VIH et de l'antigène p24 (1999) (16)
Characterization of an old complex circulating recombinant form, CRF27_cpx, originating from the Democratic Republic of Congo (DRC) and circulating in France. (2008) (16)
Does pregnancy affect the early response to cART? (2013) (16)
HIV mediated immune aging in young adults infected perinatally or during childhood. (2019) (16)
Maternal and nenonatal tenofovir and emtricitabine to prevent vertical transmission of HIV-1: tolerance and resistance (2010) (16)
Transmission of lymphadenopathy-associated virus/human T lymphotropic virus type III in sexual partners. Seropositivity does not predict infectivity in all cases. (1986) (15)
CD4 percentages and total lymphocyte counts as early surrogate markers for pediatric HIV-1 infection in resource-limited settings. (2006) (15)
Predictive value of viral load and other markers for progression to clinical AIDS after CD4+ cell count falls below 200/μL (1998) (15)
CCR2B-64I chemokine receptor allele and mother-to-child HIV-1 transmission or disease progression in children. French pediatric HIV infection study group. (1999) (14)
How much would the safety of blood transfusion be improved by including p24 antigen in the battery of tests? (1995) (14)
Désir d’enfant chez les personnes vivant avec le VIH : nouvelles recommandations 2013 du groupe d’experts français (2014) (14)
Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIV-infected patients. SEROCO Study Group. (1994) (14)
HIV-1-RNA in seminal plasma correlates with detection of HIV-1-DNA in semen cells, but not with CMV shedding, among MSM on successful antiretroviral regimens. (2016) (14)
Virological response and resistances over 12 months among HIV-infected children less than two years receiving first-line lopinavir/ritonavir-based antiretroviral therapy in Cote d’Ivoire and Burkina Faso: the MONOD ANRS 12206 cohort (2017) (14)
Estimation of HIV-1 DNA Level Interfering with Reliability of HIV-1 RNA Quantification Performed on Dried Blood Spots Collected from Successfully Treated Patients (2016) (14)
Acyclovir in preventing cytomegalovirus infection in kidney transplant recipients: A case‐controlled study (1993) (14)
Evaluation of dried blood spot diagnosis using HIV1-DNA and HIV1-RNA Biocentric assays in infants in Abidjan, Côte d'Ivoire. The Pedi-Test DBS ANRS 12183 Study. (2013) (14)
HIV Infection in the Native and Allograft Kidney: Implications for Management, Diagnosis, and Transplantation. (2017) (14)
New Highly Sensitive Real-Time PCR Assay for HIV-2 Group A and Group B DNA Quantification (2017) (13)
Prevalence of CXCR4-tropic viruses in clustered transmission chains at the time of primary HIV-1 infection. (2013) (13)
MHC-driven HIV-1 control on the long run is not systematically determined at early times post-HIV-1 infection (2013) (13)
Heterogeneous HIV-1 Reactivation Patterns of Disulfiram and Combined Disulfiram+Romidepsin Treatments (2019) (13)
Emtricitabine Seminal Plasma and Blood Plasma Population Pharmacokinetics in HIV-Infected Men in the EVARIST ANRS-EP 49 Study (2015) (13)
CCR5 antagonists: a therapeutic option in HIV-1 perinatally infected children experiencing virologic failure? (2012) (12)
A vaccinia-based elispot assay for detection of CD8+ T cells from HIV-1 infected children. (2005) (12)
DIAGNOSIS OF TOXOPLASMA ENCEPHALITIS IN ABSENCE OF NEUROLOGICAL SIGNS BY EARLY COMPUTERISED TOMOGRAPHIC SCANNING IN PATIENTS WITH AIDS (1984) (12)
Human immunodeficiency virus‐1 infection in neonates: correlation of plasma and cellular viremia and clinical outcome (1997) (12)
Acquired immunodeficiency syndrome (AIDS) in Africans. (1984) (12)
CCR2B-64I Chemokine Receptor Allele and Mother-to-Child HIV-1 Transmission or Disease Progression in Children (1999) (12)
Interlaboratory quality control of total HIV‐1 DNA load measurement for multicenter reservoir studies (2017) (12)
Low-dose zidovudine in children with an human immunodeficiency virus type 1 infection acquired in the perinatal period. (1991) (12)
Nonreactive Human Immunodeficiency Virus Type 1 Rapid Tests After Sustained Viral Suppression Following Antiretroviral Therapy Initiation During Primary Infection (2018) (12)
Longitudinal comparison of HIV-1 RNA burden in plasma and cerebrospinal fluid in two patients starting triple combination antiretroviral therapy. (1998) (11)
In Untreated HIV-1–Infected Children, PBMC-Associated HIV DNA Levels and Cell-Free HIV RNA Levels Are Correlated to Distinct T-lymphocyte Populations (2010) (11)
Randomized study of two doses of didanosine in children infected with human immunodeficiency virus. (1993) (11)
Optimal maturation of the SIV-specific CD8+ T-cell response after primary infection is associated with natural control of SIV. ANRS SIC study (2019) (11)
Interruption of cART in Clinical Practice Is Associated With an Increase in the Long-Term Risk of Subsequent Immunosuppression in HIV-1-Infected Children (2014) (11)
Immunological and virological features of HIV‐infected patients with increasing CD4 cell numbers despite virological failure during protease inhibitor‐based therapy (2002) (11)
Lack of HPA-23 antiviral activity in HIV-infected patients without AIDS. (1989) (11)
Zidovudine genotypic resistance in HIV-1-infected newborns in the French perinatal cohort. (2001) (10)
Poor recognition of HIV-1 Nef protein by CD8 T cells from HIV-1-infected children: impact of age. (2006) (10)
La résistance du VIH-1 aux antirétroviraux chez les enfants infectés : du nouveau-né à l'adolescent (2007) (10)
Increasing contribution of integrated forms to total HIV DNA in blood during HIV disease progression from primary infection (2019) (10)
In HIV type 1-infected children cytotoxic T lymphocyte responses are associated with greater reduction of viremia under antiretroviral therapy. (2005) (10)
HIV-DNA in the Genital Tract of Women on Long-Term Effective Therapy Is Associated to Residual Viremia and Previous AIDS-Defining Illnesses (2013) (10)
HIV DNA: a clinical marker of HIV reservoirs (2018) (10)
Zidovudine therapy in children with acquired immunodeficiency syndrome. (1988) (9)
HIV-1 co-infection prevalence in two cohorts of early HIV-1 seroconverters in France (2007) (9)
Factors Correlated With Homosexually Acquired Human Immunodeficiency Virus Infection in the Era of “Safer Sex” Was the Prevention Message Clear and Well Understood? (1993) (9)
Aide médicale à la procréation chez les personnes infectées par le VIH (2008) (9)
CCR5 delta32 deletion and reduced risk of toxoplasmosis in persons infected with human immunodeficiency virus type 1. The SEROCO-HEMOCO-SEROGEST Study Groups. (1999) (8)
Barriers to a Cure: New concepts in targeting and eradicating HIV-1 reservoirs (2013) (8)
Herpesvirus infection of the respiratory tract in patients with alcoholic hepatitis. (1992) (8)
[HIV and pregnancy: 2013 guidelines from the French expert working group]. (2014) (8)
Les nouvelles données de l'interprétation de la sérologie de la toxoplasmose par l'évaluation comparée d'anciennes et de nouvelles techniques sérologiques (1990) (8)
LACK OF EVIDENCE FOR HUMAN OR SIMIAN T-LYMPHOTROPIC VIRUSES TYPE III INFECTION IN PYGMIES (1986) (8)
Immunological success is predicted by enfuvirtide but not interleukin-2 therapy in immunodepressed patients (2009) (8)
Cytomegalovirus infections after kidney transplantation: identical risk whether donor or recipient is the virus carrier. (1991) (8)
[Reproductive options for people living with HIV: 2013 guidelines from the French expert working group]. (2014) (7)
Trousses de dépistage des anticorps anti-VIH1 et VIH2 (1994) (7)
X4 Tropic Multi-Drug Resistant Quasi-Species Detected at the Time of Primary HIV-1 Infection Remain Exclusive or at Least Dominant Far from PHI (2011) (7)
Short-term evaluation of zidovudine-treated patients: decrease in plasma and cellular viraemia titres. (1992) (7)
Risk-benefit analysis of nucleic acid testing: the French experience. (1999) (7)
Predictive value of viral load and other markers for progression to clinical AIDS after CD4+ cell count falls below 200/microL. SEROCO & HEMOCO Study Group. (1998) (7)
Polymorphisme génétique des souches de cytomégalovirus responsables d’infections congénitales (2004) (7)
What Is the most Important for Elite Control: Genetic Background of Patient, Genetic Background of Partner, both or neither? Description of Complete Natural History within a Couple of MSM (2017) (7)
Contributions CCR 5 Chemokine Receptor Variant in HIV-1 Mother-to-Child Transmission and Disease Progression in Children (2001) (7)
Evaluation des trousses de dépistage de l'antigène p24 du VIH (1997) (7)
Comparative performance of the Biocentric Generic Viral Load, Roche CAP/CTM v1.5, Roche CAP/CTM v2.0 and m2000 Abbott assays for quantifying HIV-1 B and non-B strains: Underestimation of some CRF02 strains. (2019) (6)
[Sudden infant death syndrome]. (1989) (6)
Long-Term HIV-1 Virologic Control in Patients on a Dual NRTI Regimen (2013) (6)
Use of Reverse Transcription-PCR-Based Assays for Quantification of HIV-1 in Dried Blood Spots Requires Specific HIV-1 RNA Isolation for Monitoring of Antiretroviral Treatment Efficiency (2014) (6)
Quantitation of HIV-1 RNA in breast milk by real time PCR. (2006) (6)
Gag-Specific CD4 and CD8 T-Cell Proliferation in Adolescents and Young Adults with Perinatally Acquired HIV-1 Infection Is Associated with Ethnicity — The ANRS-EP38-IMMIP Study (2015) (6)
Ultrasensitive Detection of p24 in Plasma Samples from People with Primary and Chronic HIV-1 Infection (2021) (6)
Comments on "cytomegalovirus (CMV)-encoded UL144 (truncated tumor necrosis factor receptor) and outcome of congenital CMV infection". (2007) (6)
Exon 4 of the Human Cytomegalovirus (CMV) Major Immediate-Early Gene as a Target for CMV Real-Time PCR (2008) (6)
[Multicenter French cohort of adults with HIV infection. Description and course after 4 years of follow-up. SEROCO]. (1994) (6)
Tolerance and viral resistance after single-dose nevirapine (NVP) and short-course of tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) to prevent mother-to-child transmission (PMTCT) of HIV-1: the TEmAA ANRS 12109 phase II trial, step 1 (2008) (6)
[West Nile virus meningomyeloencephalitis--value of interferon assays in primary encephalitis]. (1984) (6)
Cytomegalovirus infection in HIV-infected versus non-infected infants and HIV disease progression in Cytomegalovirus infected versus non infected infants early treated with cART in the ANRS 12140—Pediacam study in Cameroon (2017) (5)
Etiologies virales du SIDA: Faits et hypothèses (1984) (5)
Appointment reminders to increase uptake of HIV retesting by at‐risk individuals: a randomized controlled study in Thailand (2020) (5)
Nouvelle évaluation de 3 trousses immunoenzymatiques de dépistage des anticorps anti-LAV (1986) (5)
8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19–22 July 2015, Vancouver, Canada (2015) (5)
Prévention de la varicelle chez les transplantés rénaux (1998) (5)
Acceptability of on-site rapid HIV/HBV/HCV testing and HBV vaccination among three at-risk populations in distinct community-healthcare outreach centres: the ANRS-SHS 154 CUBE study (2020) (5)
Seronegativation in Early Treated HIV-Infected Infants: Frequency and Potential Implications on Care and Follow-up in a Resource-Limited Country (2011) (5)
[Acquired immunodeficiency syndrome in 4 homosexuals]. (1983) (5)
[Assisted procreation technology and people with HIV]. (2008) (5)
Month follow up of African children following vaginal cleansing with benzalkonium chloride of their HIV infected mothers during late pregnancy and delivery (2002) (5)
[Sudden crib death. Experience in a referral center 1986-1991]. (1993) (5)
Rilpivirine in HIV-1-positive women initiating pregnancy: to switch or not to switch? (2020) (4)
Residual HIV-1 replication may impact immune recovery in patients on first-line lopinavir/ritonavir monotherapy. (2015) (4)
Genital Human Immunodeficiency Virus-1 RNA and DNA Shedding in Virologically Suppressed Individuals Switching From Triple- to Dual- or Monotherapy: Pooled Results From 2 Randomized, Controlled Trials. (2020) (4)
Human immunodeficiency virus-1 infection in neonates: correlation of plasma and cellular viremia and clinical outcome. French Pediatric Cohort Study Group. (1997) (4)
Longitudinal study of plasma HIV‐1 RNA concentrations during the asymptomatic stage of HIV infection measured using AMPLICOR HIV monitor and NASBA HIV‐1 RNA QT tests (1998) (4)
Detection of HCV RNA in semen (2000) (4)
Population Pharmacokinetic Modeling of Tenofovir in the Genital Tract of Male HIV-Infected Patients (2016) (4)
Drug-Free Remissions for HIV-Infected Individuals HIV Persistence and the Prospect of Long-Term (2010) (4)
HIV-1 DNA concentrations and evolution among African HIV-1-infected children under antiretroviral treatment (ANRS 1244/1278). (2014) (4)
HIV-1 quantification in infected children born to seropositive mothers. (1993) (4)
S03-04 OA. Transitional and central memory CD4 T cells are highly infected in long term non progressors and elite controllers (2009) (4)
The possible role of a new lymphotropic retrovirus (LAV) in the pathogeny of AIDS and AIDS-related diseases. (1985) (4)
Relationship of CD4+ T-cell counts and plasma HIV-1 RNA levels with serological HBeAg/anti-HBe patterns obtained in West-African HBV-HIV-1-co-infected children. (2009) (4)
LAV type II: un second rétrovirus associé au SIDA en Afrique de l'Ouest (1986) (4)
Novel role of UHRF1 in the epigenetic repression of the latent HIV-1 (2022) (4)
Impact of Counseling Methods on HIV Retesting Uptake in At-Risk Individuals: A Randomized Controlled Study (2019) (4)
Association between cellular HIV-1 DNA level and mortality in HIV-1 infected African adults starting ART with high CD4 counts (2020) (4)
VIH et grossesse (2002) (4)
Relationship between antiretroviral drug plasma concentrations and viral load in children. (2003) (4)
GRANULOCYTE-ASSOCIATED IMMUNOGLOBULINS IN RENAL TRANSPLANT RECIPIENTS WITH CYTOMEGALOVIRUS INFECTION (1988) (4)
Efficacy and safety of interferon and ribavirin therapy in HIV-HCV coinfected patients (2000) (3)
Factors associated with being overweight and obesity in people living with HIV on antiretroviral therapy : socio-clinical, inflammation, and metabolic markers. (2021) (3)
LAV/HTLV-III ANTIBODIES IN CONNECTIVE TISSUE DISEASES (1985) (3)
Transient viral exposure drives functionally-coordinated humoral immune responses in HIV-1 post-treatment controllers (2022) (3)
Le sida pédiatrique, 30 ans plus tard (2013) (3)
Gag-Specific CD4 T Cell Proliferation, Plasmacytoid Dendritic Cells, and Ethnicity in Perinatally HIV-1-Infected Youths: The ANRS-EP38-IMMIP Study. (2016) (3)
[HIV-1 quantitative dynamics in vivo: a review of mathematical models]. (2000) (3)
Cidofovir for Adenovirus Infection after Allogenic Hematopoietic Stem Cell Transplantation: A Single-Center Experience of 16 Childrens. (2004) (3)
CCR5 D32 Deletion and Reduced Risk of Toxoplasmosis in Persons Infected with Human Immunodeficiency Virus Type 1 (1999) (3)
Mother-to-Child Transmission of HIV-2 Infection from 1986 to 2007 in the ANRS French Perinatal Cohort EPF-CO 1 (2010) (3)
CorrigendumCorrigendum to “Cross-clade-specific cytotoxic T lymphocytes in HIV-1-infected children” [Virology 250 (1998) 316324] (2008) (3)
Epstein-Barr virus (EBV) early-antigen antibodies and EBV DNA load in blood, in posttransplantation lymphoproliferative disease. (2004) (3)
One or two enzyme-linked immunosorbent assay tests on the first serum sample for initial diagnosis of HIV-1 infection? (2008) (3)
Lack of anti-p27nef antibody detection in HIV-seronegative high-risk people. (1989) (3)
Decreased peripheral circulation of HIV-infected cells in a subset of long-term nonprogressors. The French ALT Study Group. (1999) (3)
Infection par le virus de l'hépatite C chez des enfants nés de mères HIV (1990) (3)
HIV-1 viral load and CD4 count in untreated children with vertically acquired mild or asymptomatic disease (1997) (3)
[Virologic diagnosis of HIV infection in the pregnant woman and newborn infant]. (1990) (3)
Identification of a new factor involved in DNA methylation-mediated repression of latent HIV-1 (2017) (3)
[Genetic polymorphism of cytomegalovirus strains responsible of congenital infections]. (2004) (2)
[HIV-1 drug resistance in French infected-children: from newborn to adolescent]. (2007) (2)
[Nervous system involvement in HIV1 infections in infants]. (1987) (2)
Undetectable HIV‐1 RNA load with the Cobas TaqMan v1.0 in a patient diagnosed at the time of primary HIV‐1 infection (2010) (2)
[Pediatric aids, 30 years later]. (2013) (2)
Prevention of maternal HIV transmission. Practical guidelines. (1995) (2)
Immunity, inflammation and reservoir in patients at an early stage of HIV infection on intermittent ART (ANRS 141 TIPI Trial). (2016) (2)
HIV viral load algorithm: what are the needs in the field? (2019) (2)
Strategy of cytomegalovirus infection prevention in renal transplantation. (1994) (2)
Persistence of anal squamous intraepithelial lesions and anal HPV infection in HIV-infected patientsdespite immune restoration under cART (2010) (2)
Prevalence and Clinical Impact of Norovirus Fecal Shedding in Children with Inherited Immune De fi ciencies (2012) (2)
Early diagnosis of HIV-1 infection in newborns, in the context of prevention of mother-to-child transmission with HAART (Perinatal Cohort ANRS Co 01) (2008) (2)
Mesure de l’ARN VIH-1 et du taux de lymphocytes TCD4 dans le suivi du traitement antirétroviral de patients infectés par le VIH en Côte d’Ivoire (2019) (2)
Virus et sperme : implications pour l'assistance médicale à la procréation (AMP) (2006) (2)
Réservoirs et réponses immunitaires au cours de l’histoire naturelle de l’infection à VIH-1 (2013) (2)
Réévaluation de la sensibilité de 8 trousses unitaires rapides de dépistage des anticorps anti-VIH (1995) (2)
La grippe aviaire : implications possibles sur la santé humaine (2005) (2)
Principales hypothèses étiologiques du SIDA (1984) (2)
Conduite et difficultés de la sérologie HIV (1987) (2)
Contribution of nucleic acid amplification techniques to the safety of blood components in France (1998) (1)
[HIV and pregnancy]. (2002) (1)
HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007 – 12: impact on susceptibility to ﬁrst-line strategies (2015) (1)
No barrier to care, yet disparities in the HIV care continuum in France: a nationwide population study. (2021) (1)
Synergistic activation of HIV-1 expression by compounds targeting the positive transcription elongation factor b (P-TEFb) and by inducers of the NF-kB signaling pathway (2013) (1)
[Diagnosis and virologic monitoring of HIV infection]. (1999) (1)
A guinea pig model for cytomegalovirus congenital infection: dose-effect and vertical transmission rate (2008) (1)
OP 2.6 – 00135 Constitutive NKG2A levels and timing of antiretroviral therapy initiation impact the potential role of NK cells after treatment interruption - the pVISCONTI study (2022) (1)
A Novel Human Lymphotropic Retrovirus (LAV): New Data on Its Biology and Role in AIDS (1985) (1)
Very early diagnosis of HIV infection in newborn at day 0–day 3 on DBS in Cambodia (2009) (1)
Association of Plasma sVCAM-1 and sCD14 with Mortality in HIV-1 Infected West African Adults with High CD4 Counts (2020) (1)
Novel Role of UHRF1 in DNA methylation-mediated repression of latent HIV-1 (2021) (1)
False-negative Results of Human Immunodeficiency Virus (HIV) Rapid Testing in HIV Controllers. (2019) (1)
Cell and tissue reservoirs of HIV-1: dynamics during infection. (2019) (1)
Quantifying the burden of influenza: a prospective household contact study in France☆ (2001) (1)
O 3 Heme-arginate as a latency-reversing agent for HIV-1 cure (1)
Prevention of Maternal HIV Transmission (2012) (1)
[Survival of the human immunodeficiency virus (HIV-1) in Triatoma infestans (Klug, 1834)]. (1992) (1)
[Absence of anti-LAV antibodies in connective tissue diseases]. (1986) (1)
Diversity of HIV-1 genetic subtypes in France, in the context of mother-to-child transmission. The French Pediatric Cohort Study Group. (2000) (1)
Modeling SIV kinetics supports that cytotoxic response drives natural control and unravels heterogeneous populations of infected cells (2020) (1)
Track A Basic Science (2012) (1)
[Infection of the newborn infant by the human immunodeficiency virus]. (1988) (1)
TESTING FOR HUMAN IMMUNODEFICIENCY VIRUS P24 ANTIGEN. AUTHORS' REPLIES (1996) (1)
Aspects virologiques et immunologiques de la primo-infection par le VIH-1 (2002) (1)
La quantification de l’ADN-VIH : où, comment, pourquoi ? (2009) (1)
Post-treatment Controllers (2014) (1)
La mort subite du nourrisson. (1990) (1)
, with Plasma Viral Load in Infected Children Correlate Positively T Cells + Gamma-Interferon-Producing CD 8 Immunodeficiency Virus Type 1-Specific Frequencies of Ex Vivo-Activated Human (2002) (1)
Confinée mais mobilisée, l’Académie nationale de médecine au temps de la Covid-19 (2020) (1)
Decreased darunavir concentrations during once-daily co-administration with maraviroc and raltegravir: OPTIPRIM-ANRS 147 trial (2018) (1)
Immunothérapie passive dans le SIDA : utilisation transfusionnelle de plasma riche en anticorps anti-p25 (essai de phase I) (1991) (1)
La toxicité mitochondriale des inhibiteurs nucléosidiques de la transcriptase inverse du VIH (2004) (1)
0.1. Association of plasma sVCAM-1 and sCD14 with mortality in HIV-1 infected West African adults with high CD4 counts. (2020) (1)
Le risque viral en transfusion sanguine (1995) (1)
Détermination des sous-populations lymphocytaires T: application à la pneumologie, à la pathologie infectieuse et à la cancérologie (1984) (1)
mulTI-cohorT GeneTIc assocIaTIon sTudy reVeals cXcr 6 as a new chemokIne recePTor InVolVed In aIds lonG-Term non-ProGressIon (2011) (1)
Le diagnostic de l'infection à VIH chez le nouveau-né, en Europe et dans les pays en voie de développement (1996) (1)
La transmission materno-fœtale du VIH (1998) (1)
Caractéristiques des patients HIV controllers : résultats de la cohorte ANRS CO18 (2013) (1)
Etiologie virale du SIDA (1986) (1)
Once-daily dolutegravir versus darunavir plus cobicistat in adults at the time of primary HIV-1 infection: the OPTIPRIM2-ANRS 169 randomized, open-label, Phase 3 trial. (2022) (1)
[The pitfalls of HIV serology]. (1990) (1)
Spatiotemporal dynamics of HIV-1 transmission in France (1999–2014) and impact of targeted prevention strategies (2017) (1)
6-month eff i c a c y, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d’Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial (1999) (0)
[Confined but mobilized, the National Academy of Medicine at the time of Covid-19]. (2020) (0)
Gag-Specific CD8 T-Cell Proliferation Is Associated With Higher Peripheral Blood Levels of Transforming Growth Factor-β and Gut-Homing T Cells in Youths Perinatally Infected With Human Immunodeficiency Virus-1: The ANRS-EP38-IMMIP Study (2016) (0)
Detection of hepatitis b virus dna and hbsag polyclonal and monoclonal anti hbs radioimmunoassays in sera of algerian children with acute non a non b hepatitis (1987) (0)
Impact of antihiv tritherapy on HCV infection: biological and virological analysis (1998) (0)
Perinatal transmission of Cytomegalovirus (CMV) in children born to HIV positive and negative women in Cameroon (2009) (0)
Pe rsistent mitochondrial dysfunction and perinatal exposure to a n t i r e t r oviral nucleoside analogues (1999) (0)
Seroepidemiological Study of Lymphadenopathy Associated Virus, by Elisa, in Acquired Immunodeficiency Syndrome (1985) (0)
Elite and viremic HIV-1 controllers in West Africa (2021) (0)
Immunological studies on the french cohort of 111 HIV-1 infected long-term non progressors (LT-NP) (1997) (0)
In-Depth Characterization of Full-Length Archived Viral Genomes after Nine Years of Posttreatment HIV Control (2023) (0)
Utilisation de la biothèque dans les cohortes hospitalières SEROCO et HEMOCO de patients infectés par le VIH (2003) (0)
Two Highly Variable Vpr 84 and Vpr 85 Residues within the HIV-1-Vpr C-Terminal Protein Transduction Domain Control Transductionnal Activity and Define a Clade Specific Polymorphism (2014) (0)
Heterogeneous HIV reactivation patterns of DSF and combined DSF+romidepsin treatments (2018) (0)
[Viral etiologies of AIDS: facts and hypotheses]. (1984) (0)
A Third Pattern of Disease Progression in Children Infected With Human Immunodeficiency Virus-Reply (1991) (0)
Transmission du HIV de la mère à l'enfant (2003) (0)
Aucune infection due au virus de l'immunodéficience humaine type 2 décelée chez 883 toxicomanes (1988) (0)
HIV-specific CTL in infected children (1997) (0)
P16-11. HLA-B57/5801 induces preferential CD27 expression on HIV-Gag but not Nef specific central memory CD8+T cells controlling HIV (2009) (0)
Hepatitis C detection (2001) (0)
[Infection by hepatitis C virus in infants of HIV mothers. The HIV Infection in Newborn French Collaborative Study Group]. (1990) (0)
Immune responses and latent tissue reservoirs during the course of HIV-1 infection. (2013) (0)
Access to HIV medical care: a roundtable. (2000) (0)
41 Vitamin D level in cART treated patients is critical for HIV reservoir size (2016) (0)
Oral abstracts of the HIV Cure and Reservoir Symposium 2017 (2017) (0)
La dynamique de la réplication du VIH dans l'organisme (1999) (0)
[Severe respiratory syncytial virus infections. Study of 87 infants hospitalized in an epidemic]. (1989) (0)
The frequency of HIV-specific CD8 T lymphocytes is inversely correlated to HIV DNA levels in untreated infected children (2008) (0)
High prevalence of cytomegalovirus (CMV) infection in infants born to HIV infected mothers–ANRS French Perinatal Cohort (EPF) (2008) (0)
[Diagnosis of HIV infection in newborn infants in Europe and in developing countries]. (1996) (0)
Early assessment of antiretroviral efficacy is critical to prevent the emergence of resistance mutations in HIV-tuberculosis coinfected patients: a substudy of the CARINEMO-ANRS12146 trial (2019) (0)
HIV-1-RNA and total HIV-1-DNA loads in the genital compartment in men receiving dolutegravir- versus darunavir-based combined ART (cART) regimens during primary HIV infection. (2022) (0)
Short communication Quantitation of HIV-1 RNA in breast milk by real time PCR (2006) (0)
Evaluation of HIV Viral Load Activity at the Bacteriology-Virology Laboratory in the University Hospital Center of Brazzaville (2019) (0)
Le point sur la transmission du VIH de la mère à l'enfant en 1997 (1997) (0)
Early protective effect of : relationship with viral load ccr-5 : relationship with viral load Δ32 heterozygosity on Hiv-1 disease progression: relationship with viral load (1997) (0)
Gag-specific CD8 T-cell proliferation is associated with higher peripheral blood levels of TGF- β and gut-homing T cells in youths perinatally infected with HIV-1 – The ANRS- EP38-IMMIP Study (2018) (0)
L’observatoire national ANRS des « HIV Controllers » : bilan après deux années de recrutement (2008) (0)
Le diagnostic virologique de l'infection à cytomégalovirus humain : CMV (2001) (0)
[Passive immunotherapy in AIDS: transfusion of plasma rich in anti-p25 antibody (phase I trial)]. (1991) (0)
Is marital status and information of the father associated with access to prevention of mother-to-child HIV transmission? (2009) (0)
No association between human herpesvirus 6 reactivation and cryptococcosis in human immunodeficiency virus-infected patients. (2009) (0)
Gag-specific CD4 T-cell proliferation, plasmacytoid dendritic cells and ethnicityin perinatally HIV-1-infected youths – The ANRS-EP38-IMMIP Study Short title: T-cell proliferation and dendritic cells (2020) (0)
Pro-viral DNA and antiretroviral treatment simplification (2010) (0)
Purified and isolated retrovirus of hiv (1993) (0)
Le diagnostic de l'infection à VIH chez l'enfant né de mère séropositive (1997) (0)
Le sida pédiatrique (1994) (0)
L'ADN VIH-1: évolution au cours de l'infection, valeur pronostique et intérêt (2009) (0)
Le SIDA du nouveau-né (1994) (0)
Le diagnostic virologique de l'infection a cytomégalovirus en transplantation rénale (1997) (0)
Virémies quantitatives et antigénémies p24 dans le suivi à court terme du traitement par la zidovudine de vingt patients infectés par le VIH (1993) (0)
COL05-02 : Résultats de l’essai OPTIPRIM-ANRS 147 (2014) (0)
La sérologie VIH1 et VIH2 bonne pratique et interprétation (1988) (0)
P16-37. HIV controllers with weak CD8+ T cell responses maintain a tight control of infection despite carrying infectious viruses (2009) (0)
Les sondes nucléiques froides et leurs applications diagnostiques (1987) (0)
Mesure de la charge virale VIH: actualités en 1995 (1995) (0)
Total HIV DNA: a global marker of HIV persistence (2018) (0)
Les antirétroviraux utilisés en multithérapie: Molécules, cibles, pharmacologie, bases des associations thérapeutiques (2000) (0)
Évolution clinique des patients diagnostiqués au moment de la primo-infection à VIH-1 en France : suivi à dix ans dans la cohorte française ANRS PRIMO (2008) (0)
Traiter tôt l’infection à VIH : Pourquoi ? (2018) (0)
Fifth International Conference on AIDS : the Scientific and Social Challenge; symposium; laboratory issues in the diagnosis of AIDS (1989) (0)
Analyse finale à 96 semaines des résultats des patients infectés par le VIH-1 et randomisés dans le bras monothérapie lopinavir/ritonavir en première ligne de traitement dans le cadre de l’essai Monark (2008) (0)
Premiers résultats de l’étude ANRS-CUBE : triple dépistage VIH-VHB-VHC par tests rapides à Paris (2016) (0)
Early diagnosis of HIV-1 infection in Cambodian infants (2008) (0)
Présence d'anticorps anti-LAV (Lymphadenopathy-Associated-Virus) chez des hémophiles Francais* (1985) (0)
SIDA, maladies associées : pistes pour de nouveaux médicaments (1996) (0)
Les rétrovirus humains (1989) (0)
La notion de réservoir dans l'infection à VIH (2002) (0)
COL05-03 : Un traitement précoce en primo-infection VIH protège les CD4 mémoires centrales et naïves et peut induire une rémission de l’infection (2014) (0)
Indications, techniques, fiabilité de la sérologie LAV/HTLV-III en janvier 1986 (1986) (0)
Le diagnostique virologique de l'infection à cytomégalovirus humain (2001) (0)
[Avian flu: possible implications for human health]. (2005) (0)
[Virologic diagnosis of HIV infection in children]. (1992) (0)
Reactivation of postintegration HIV-1 latency : potential therapeutic approach to purge the viral reservoirs (2014) (0)
Intrinsic resistance to HIV-1 of macrophages and CD4+ T cells from HIV controllers (2011) (0)
Hepatitis viruses. (1994) (0)
[Quantitative viremia and p24 antigenemia in short-term follow-up of the treatment with zidovudine in twenty HIV infected patients]. (1993) (0)
Acyclovir in preventing cytomegalovirus infection in kidney transplant recipients: a case-controlled study. (1993) (0)
Gag-specific CD 4 T-cell proliferation , plasmacytoid dendritic cells and ethnicityin perinatally HIV-1-infected youths – The ANRS-EP 38-IMMIP Study Short title : T-cell proliferation and dendritic cells (2019) (0)
Absence d'anticorps anti-LAV au cours de connectivités (1986) (0)
[HIV infection: Which therapeutical challenges remain in 2009?]. (2010) (0)
UHRF1 in DNA methylation-mediated control of HIV-1 latency (2018) (0)
53: HHV-6 and EBV DNA quantification in lymph nodes of Hodgkin's patients (2006) (0)
[Evaluation of HIV screening tests. Retrovirus Group of the French Society of Blood Transfusion]. (1994) (0)
Post treatment Controllers : What do they tell us ? (2019) (0)
Diagnosis and treatment of HIV primary infection: the earlier, the better ! (2017) (0)
Insectes hématophages et virus de l'immuno-déficience humaine (VIH): étude de la survie du VIH chez Triatoma infestans (KLUG 1884) (1993) (0)
HIV mother-to-child transmission (1998) (0)
Both HLA-B*57 and Plasma HIV RNA Levels Contribute to the HIV-Speciﬁc CD8 (cid:2) T Cell Response in HIV Controllers (2013) (0)
Thrombophlebites cerebrales et virus (1987) (0)
Is access to care different for women from sub-Saharan Africa than for French women according to prevention of mother-to-child HIV transmission in France? (2008) (0)
Frequency of resistant virus and options for a second-line treatment for HIV-1 infected children under HAART in Mozambique (2008) (0)
PCR multiplex sur le LightCycler utilisant des sondes d'hydrolyse et d'hybridation : application à la quantification du provirus VIH-1 (2001) (0)
The National Academy of Medicine facing Covid-19 (2020) (0)
Patient-Speciﬁc Cytotoxic T-Lymphocyte Cross-Recognition of Naturally Occurring Variants of a Human Immunodeﬁciency Virus Type 1 (HIV-1) p24 gag Epitope by HIV-1-Infected Children (2001) (0)
HDAC inhibitors and the NF-B inducer prostratin cooperate to reactivate latent HIV-1 proviruses in cellular reservoirs (2007) (0)
Reactivation of HIV-1 gene expression by DNA methylation or histone methyltransferase inhibitors (2011) (0)
Gag-Specific CD8 T Cell Responses Cells from HIV Controllers: Association with Heterogeneity in HIV Suppression by CD8 T (2013) (0)
Pneumopathies interstitielles au cours du syndrome d'immunodépression acquise (S.I.D.A.)* (1985) (0)
Reply to Spellberg (2006) (0)
Les variants du SARS-CoV-2 face au dépistage et aux vaccins (2021) (0)
Evaluation des réactifs HIV (1994) (0)
HIV stigma limits the effectiveness of PMTCT in Guinea: the ANRS 12344-DIAVINA study (2022) (0)
[Virologic diagnosis of human immunodeficiency]. (1991) (0)
Diversité des marqueurs immunovirologiques précoces et corrélation avec les signes cliniques au moment de la primo-infection par le VIH : résultats de la cohorte ANRS PRIMO CO 06 (2008) (0)
Le diagnostic de l'infection par VIH chez l'enfant (1996) (0)
Biotechnology in the Development of HIV Diagnostic Procedures (1988) (0)
L’infection à VIH : quels enjeux thérapeutiques en 2009 ? Quel a été l’impact sur la virologie médicale en France ?☆ (2010) (0)
CONCISE COMMUNICATIONS CCR5 D32 Deletion and Reduced Risk of Toxoplasmosis in Persons Infected with Human Immunodeficiency Virus Type 1 (1999) (0)
[Management of the bank of biological material in the hospital-based SEROCO and HEMOCO cohorts of HIV-infected patients]. (2003) (0)
Transient viral exposure drives functionally-coordinated humoral immune responses in HIV-1 post-treatment controllers (2022) (0)
Stratégie de prévention de l'infection à cytomégalovirus en transplantation rénale (1993) (0)
To cause of AIDS suitable retrovirus of type HIV-2, as well as its antigen- and nucleic acid constituents. (1987) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Christine Rouzioux?

Christine Rouzioux is affiliated with the following schools: